This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Shilpa Medicare Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Lavkumar Upalla: Innovator in Pharmaceutical Processes
Introduction
Lavkumar Upalla is a notable inventor based in Vizianagaram, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of complex compounds. His work is characterized by a focus on improving existing processes to enhance efficiency and effectiveness.
Latest Patents
Lavkumar Upalla holds 1 patent for his innovative work titled "Process for preparing dasatinib monohydrate." This patent describes an improved method for the preparation of Dasatinib monohydrate, which is crucial for its application in medical treatments. The process involves several steps that optimize the yield and purity of the compound, showcasing Upalla's expertise in pharmaceutical chemistry.
Career Highlights
Upalla is currently employed at Shilpa Medicare Limited, a prominent company in the pharmaceutical industry. His role involves research and development, where he applies his knowledge to create better pharmaceutical products. His dedication to innovation has positioned him as a valuable asset to his team and the company.
Collaborations
Throughout his career, Lavkumar Upalla has collaborated with several talented individuals, including Sriram Rampalli and Mohanrao Seshagiri Vijaya Murali. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Lavkumar Upalla's contributions to pharmaceutical processes exemplify the impact of innovation in medicine. His patent for the preparation of Dasatinib monohydrate highlights his commitment to improving drug development. As he continues to work at Shilpa Medicare Limited, his future endeavors are likely to yield further advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile